Cardiology

Andrew S. Bomback MD, MPH, answers our questions about malignant hypertension and how to overcome the challenges of management.

Researchers Marianne Hartford, MD, PhD, and Annica Ravn-Fischer, MD, PhD, answer our questions about their latest research that investigated gender differences in outcomes and predictors of acute coronary...

A new study examined the effects of SBP and DBP on cardiovascular outcomes in light of recently revised hypertension guidelines. Lead author Alexander Flint, MD, PhD, answers our questions about his study. ...

Though current guidelines recommend antiplatelet therapy for patients with cryptogenic stroke, new research is examining the effect of anticoagulation therapy on patient outcomes. Researcher Hooman Kamel,...

In this Q&A, Jason S. Bradfield, MD, answers our questions about his research on epicardial ablation of ventricular tachycardia and the challenges it currently presents.

Jonathan C. Hsu, MD, from the University of California San Diego, answers our questions about preventing stroke in a challenging patient population.

Lead author of the INFINITY trial, William B. White, MD, answers our questions about the preliminary results of the trial and subsequent analyses the team plans to conduct.

Nonpharmacologic options for stroke prevention in AFib exist, and John Catanzaro, MD, from the University of Florida Jacksonville shines light.

Consultant360 spoke with Dr James L Januzzi Jr, who recently co-authored the “2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart...

Tom Deering, MD, from the Piedmont Heart Institute answered our questions about pharmacological therapies for treating atrial fibrillation.